IP Verse

Nivagen Pharmaceuticals, Inc. V. Amneal Pharmaceuticals Inc. - 1:24-cv-00846

Explore the details of the Nivagen Pharmaceuticals, Inc. V. Amneal Pharmaceuticals Inc. case under case number 1:24-cv-00846 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:24-cv-00846
Filing Date
Jul 19, 2024
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent

Parties Involved in the Case

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Amneal Pharmaceuticals LLC -
Nivagen Pharmaceuticals, Inc. -

Patents Involved in the Case

This case involves 2 patents, each of which is central to the dispute. These patents may be subject to claims of infringement, challenges to their validity, or other issues concerning their scope and enforcement.

Application NumberPatent Number
-US11925661B2
-US11813291B2

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Dec 6, 2024SO ORDERED, re 90 STIPULATION TO EXTEND TIME for all Defendants to answer, move against, or otherwise respond to the Second Amended Complaint for Patent Infringement of U.S. Patents 11,813,291 and 11,925,661 (D.I. 88) to December 6, 2024 filed by Amneal Pharmaceuticals of New York, LLC, Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals, Inc., Amneal EU Ltd., Amneal Pharmaceuticals Pvt. Ltd. Signed by Judge Gregory B. Williams on 12/5/2024. (lnb)PACER Document
Dec 13, 2024SO ORDERED, re 92 STIPULATION TO EXTEND TIME to Answer, Move Against, or Otherwise Respond to Amneal Pharmaceuticals LLC's Counterclaims to January 3, 2025 filed by Nivagen Pharmaceuticals, Inc. Signed by Judge Gregory B. Williams on 12/13/2024. (lnb)PACER Document
Jan 8, 2025STIPULATION TO EXTEND TIME for Defendants to file their answering brief in opposition to Plaintiff Nivagen Pharmaceuticals, Inc.s Motion to Dismiss and Motion to Strike to January 28, 2025, and to extend the deadline for Plaintiff to file its reply brief in support of its Motion to February 11, 2025 - filed by Amneal Pharmaceuticals of New York, LLC, Amneal Pharmaceuticals Pvt. Ltd., Amneal EU Ltd., Amneal Pharmaceuticals, Inc., Amneal Pharmaceuticals LLC. (Gaza, Anne) (Entered: 01/08/2025)PACER Document
Jan 9, 2025SO ORDERED, re 96 STIPULATION TO EXTEND TIME for Defendants to file their answering brief in opposition to Plaintiff Nivagen Pharmaceuticals, Inc.s Motion to Dismiss and Motion to Strike to January 28, 2025, and to extend the deadline for Plaintiff to file its reply br filed by Amneal Pharmaceuticals of New York, LLC, Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals, Inc., Amneal EU Ltd., Amneal Pharmaceuticals Pvt. Ltd. Signed by Judge Gregory B. Williams on 1/9/2025. (lnb)PACER Document
Jan 20, 2025STIPULATION TO EXTEND TIME for Defendants to file their answering brief in opposition to Plaintiff Nivagen Pharmaceuticals, Inc.s Motion to Dismiss and Motion to Strike to February 4, 2025, and to extend the deadline for Plaintiff to file its reply brief in support of its Motion to February 21, 2025 - filed by Amneal Pharmaceuticals of New York, LLC, Amneal Pharmaceuticals Pvt. Ltd., Amneal EU Ltd., Amneal Pharmaceuticals, Inc., Amneal Pharmaceuticals LLC. (Gaza, Anne) (Entered: 01/20/2025)PACER Document
Jan 22, 2025[SEALED] ANSWER to 91 Answer to Amended Complaint,, Counterclaim, [Partial Answer to Counterclaims] by Nivagen Pharmaceuticals, Inc..(Moshos, Andrew) (Entered: 01/22/2025)PACER Document
Jan 29, 2025REDACTED VERSION of 98 Answer to Counterclaim [Partial Answer to Counterclaims] by Nivagen Pharmaceuticals, Inc.. (Moshos, Andrew) (Entered: 01/29/2025)PACER Document
Feb 4, 2025[SEALED] ANSWERING BRIEF in Opposition re 94 MOTION to Dismiss for Failure to State a Claim [Counts V and VI of Amneal Pharmaceuticals LLC's Counterclaims and Motion to Strike Defendants' Second, Third, and Seventeenth Affirmative Defenses] filed by Amneal Pharmaceuticals of New York, LLC, Amneal Pharmaceuticals Pvt. Ltd., Amneal EU Ltd., Amneal Pharmaceuticals, Inc., Amneal Pharmaceuticals LLC.Reply Brief due date per Local Rules is 2/11/2025. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Gaza, Anne) (Entered: 02/04/2025)PACER Document
Feb 11, 2025REDACTED VERSION of 100 Answering Brief in Opposition,, by Amneal Pharmaceuticals of New York, LLC, Amneal Pharmaceuticals Pvt. Ltd., Amneal EU Ltd., Amneal Pharmaceuticals, Inc., Amneal Pharmaceuticals LLC. (Attachments: # 1 Exhibit A - B)(Gaza, Anne) (Entered: 02/11/2025)PACER Document
Feb 21, 2025REPLY BRIEF re 94 MOTION to Dismiss for Failure to State a Claim [Counts V and VI of Amneal Pharmaceuticals LLC's Counterclaims and Motion to Strike Defendants' Second, Third, and Seventeenth Affirmative Defenses] filed by Nivagen Pharmaceuticals, Inc.. (Palapura, Bindu) (Entered: 02/21/2025)PACER Document
Jan 22, 2025SO ORDERED, re 97 STIPULATION TO EXTEND TIME for Defendants to file their answering brief in opposition to Plaintiff Nivagen Pharmaceuticals, Inc.s Motion to Dismiss and Motion to Strike to February 4, 2025, and to extend the deadline for Plaintiff to file its reply br filed by Amneal Pharmaceuticals of New York, LLC, Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals, Inc., Amneal EU Ltd., Amneal Pharmaceuticals Pvt. Ltd. Signed by Judge Gregory B. Williams on 1/22/2025. (lnb)PACER Document
Dec 13, 2024REDACTED VERSION of 91 Answer to Amended Complaint,, Counterclaim, by Amneal Pharmaceuticals of New York, LLC, Amneal Pharmaceuticals Pvt. Ltd., Amneal EU Ltd., Amneal Pharmaceuticals, Inc., Amneal Pharmaceuticals LLC. (Attachments: # 1 Exhibit A - F)(Gaza, Anne) (Entered: 12/13/2024)Attachment
Feb 11, 2025REDACTED VERSION of 100 Answering Brief in Opposition,, by Amneal Pharmaceuticals of New York, LLC, Amneal Pharmaceuticals Pvt. Ltd., Amneal EU Ltd., Amneal Pharmaceuticals, Inc., Amneal Pharmaceuticals LLC. (Attachments: # 1 Exhibit A - B)(Gaza, Anne) (Entered: 02/11/2025)Attachment
Aug 27, 2024DECLARATION re 28 Answering Brief in Opposition, of Mansoor M. Amiji, Ph.D. by Amneal EU Ltd., Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Pvt. Ltd., Amneal Pharmaceuticals of New York, LLC, Amneal Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A - F, # 2 Exhibit G - K)(Gaza, Anne) (Entered: 08/27/2024)Attachment
Aug 27, 2024DECLARATION re 28 Answering Brief in Opposition, of Mansoor M. Amiji, Ph.D. by Amneal EU Ltd., Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Pvt. Ltd., Amneal Pharmaceuticals of New York, LLC, Amneal Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A - F, # 2 Exhibit G - K)(Gaza, Anne) (Entered: 08/27/2024)Attachment